HealthPhoto: Business StandardAlembic Pharma Gets USFDA Nod for Generic Ear Infection Drug
Alembic Pharmaceuticals Ltd received final approval from the USFDA for its generic Ciprofloxacin and Dexamethasone Otic Suspension USP. The drug treats ear infections in patients aged six months and older, including Acute Otitis Media and Acute Otitis Externa. It is equivalent to Sandoz's Ciprodex Otic Suspension. The market size is estimated at USD 110 million by June 2026. Alembic now has 246 ANDA approvals.
Business Standard·


